{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:40:09Z","timestamp":1794278409643,"version":"4.9.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To conduct a STARD-compliant validity that the contrast-enhanced ultrasound (CEUS) evaluation of prostate for the improvement of positive rate of biopsy and diagnostic efficiency of prostate carcinoma (PCa).<\/jats:p>\n            <jats:p>Data of 137 patients with suspected PCa who underwent relevant examinations and treatment were reviewed, and 82 of 137 patients were finally included. The patients consisted of Group 1 (26 patients) and Group 2 (42 patients) according to which they underwent transrectal ultrasound (TRUS) biopsy selected from CEUS evaluation of the prostate and who underwent TRUS-guided biopsy directly. A systematic 12-core biopsy was performed at first, and additional 1 to 2 cores biopsy was made in the suspected target area where CEUS had showed abnormal enhancement. The assumed diagnoses were compared with pathological findings.<\/jats:p>\n            <jats:p>There were 37 patients with PCa and 31 patients with benign lesions; and 14 patients without biopsy after CEUS did not find PCa emerging in follow-up (18\u201347 months). The positive rates of biopsy-malignant lesions were 73.1% and 42.8% in Group 1 and Group 2, respectively. The positive rate of biopsy in Group 1 was significantly higher than that in Group 2 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.024). The sensitivity and accuracy of TRUS biopsy and a combination of TRUS biopsy after transrectal CEUS for the evaluation of prostate benign and malignant lesion were 60% and 66.7% (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0139), and 94.4% and 88.5% (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0453), respectively.<\/jats:p>\n            <jats:p>CEUS evaluation of the prostate of PSA-elevated patient before biopsy can help select target patient with high risk of PCa, reduce unnecessary biopsy, increase detection rate of PCa, and improve diagnostic sensitivity and accuracy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019946","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:36:20Z","timestamp":1588970180000},"page":"e19946","source":"Crossref","is-referenced-by-count":13,"title":["Contrast-enhanced ultrasound evaluation of the prostate before transrectal ultrasound-guided biopsy can improve diagnostic sensitivity"],"prefix":"10.1097","volume":"99","author":[{"given":"Guangqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Size","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","first-page":"233","article-title":"Optimizing prostate biopsy","volume":"64","author":"Bostanci","year":"2012","journal-title":"Minerva Urol Nefrol"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bju.13116","article-title":"Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer","volume":"117","author":"Postema","year":"2016","journal-title":"BJU Int"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0044-101254","article-title":"The EFSUMB Guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Short Version)","volume":"39","author":"Sidhu","year":"2018","journal-title":"Ultraschall Med"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.13122393","article-title":"Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings","volume":"269","author":"Cornelis","year":"2013","journal-title":"Radiology"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.urolonc.2009.03.032","article-title":"Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer","volume":"29","author":"Seitz","year":"2011","journal-title":"Urol Oncol"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1464-410X.2009.08963.x","article-title":"Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia","volume":"105","author":"Mitterberger","year":"2010","journal-title":"BJU Int"},{"key":"R7-20240308","first-page":"21428","article-title":"Prostate cancer: a comparison of the diagnostic performance of transrectal ultrasound versus contrast enhanced transrectal ultrasound in different clinical characteristics","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/j.ejrad.2013.07.004","article-title":"The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer","volume":"82","author":"Zhao","year":"2013","journal-title":"Eur J Radiol"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.crad.2015.11.013","article-title":"Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer","volume":"71","author":"Gao","year":"2016","journal-title":"Clin Radiol"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.urology.2014.03.020","article-title":"Contrast-enhanced transrectal ultrasonography for detection and localization of prostate index tumor: correlation with radical prostatectomy findings","volume":"84","author":"Qi","year":"2014","journal-title":"Urology"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1464-410X.2011.10577.x","article-title":"Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography","volume":"109","author":"Xie","year":"2012","journal-title":"BJU Int"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.juro.2015.12.086","article-title":"Limitations of elastography based prostate biopsy","volume":"195","author":"Schiffmann","year":"2016","journal-title":"J Urol"},{"key":"R13-20240308","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cncr.29874","article-title":"Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies","volume":"122","author":"Filson","year":"2016","journal-title":"Cancer"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2214\/AJR.04.1959","article-title":"Contrast-enhanced sonography for prostate cancer detection in patients with indeterminate clinical findings","volume":"186","author":"Yi","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20240308","first-page":"295","article-title":"Prostate ultrasound imaging: evaluation of a two-step scoring system in the diagnosis of prostate cancer","volume":"24","author":"Gao","year":"2017","journal-title":"Discov Med"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00345-018-2441-1","article-title":"Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients","volume":"37","author":"Yunkai","year":"2019","journal-title":"World J Urol"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fneur.2018.00902","article-title":"Basis of shoulder nerve entrapment syndrome: an ultrasonographic study exploring factors influencing cross-sectional area of the suprascapular nerve","volume":"9","author":"Wu","year":"2018","journal-title":"Front Neurol"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2147\/DMSO.S219649","article-title":"Association between metabolic syndrome and limb muscle quantity and quality in older adults: a pilot ultrasound study","volume":"12","author":"Chang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bulcan.2016.05.006","article-title":"Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy","volume":"103","author":"Janbaziroudsari","year":"2016","journal-title":"Bull Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:10:36Z","timestamp":1709928636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019946"}},"subtitle":["A STARD-compliant article"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":20,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019946","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}